limestone has been researched along with calcium acetate in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 26 (65.00) | 29.6817 |
| 2010's | 13 (32.50) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Llach, F; Yudd, M | 1 |
| Gropper, SS; Soffer, O; Yates, LA | 1 |
| Chen, JS; Chen, PY; Chen, WY; Chung Wu, D; Huang, CL; Huang, JW; Hung, KY; Kan, YT; Lee, SH; Leu, LJ; Yang, CS | 1 |
| Bay, WH; Coyle, JD; Hoshaw-Woodard, S; Pruchnicki, MC | 1 |
| Cleveland, M | 1 |
| Martin, CJ; Reams, SM | 1 |
| Bleyer, AJ | 1 |
| Goudas, PC | 1 |
| Bommer, J; Chertow, GM; Raggi, P | 1 |
| González, A; Martín, F; Martínez, F; Sarró, F; Verdú, J | 1 |
| Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
| Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Bellasi, A; Block, GA; Galassi, A; Raggi, P; Spiegel, DM | 1 |
| Cen, KF; Liu, J; Liu, JZ; Xiao, HP; Zhou, JH | 1 |
| Carter, TB; Dansby, LM; Diskin, CJ; Radcliff, L; Stokes, TJ | 1 |
| Blair, AT; Burke, SK; Cangiano, JL; Chasan-Taber, S; Dillon, MA; Fischer, D; Garrett, L; Ling, BN; Reed, J; Suki, WN; Zabaneh, R | 1 |
| Floege, J | 1 |
| De Vos, JY; Elseviers, M | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Khan, DA; Khan, FA; Saif, I | 1 |
| Shigematsu, T; Skaguchi, T | 1 |
| Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Tsuyuki, RT | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Fan, Q; Liu, J; St Peter, WL; Weinhandl, E | 1 |
| Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
| Noto, L | 1 |
| Bondor, C; Brumboiu, A; Gherman-Caprioara, M; Kacso, I; Moldovan, D; Moldovan, I; Orasan, R; Parvu, L; Patiu, IM; Racasan, S; Rusu, C | 1 |
| Kestenbaum, B; Liu, J; Winkelmayer, WC | 1 |
| Nurulaini, H; Wong, TW | 1 |
| Carlson, HE; Zamfirescu, I | 1 |
| Chatterley, T; Dorgan, M; Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Raggi, P; Tsuyuki, RT; Vandermeer, B | 1 |
| Bennett-Jones, D; Dasgupta, I; McVeigh, G; Shroff, R | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
| Huang, Y; Mao, Z; Wang, Y; Xie, G; Yang, B; Zhang, H | 1 |
| Bose, A; Dan, S; Harjoh, N; Pal, TK; Wong, TW | 1 |
| Neradova, A; Schumacher, SP; Schurgers, LJ; Vervloet, MG | 1 |
| Boonsuan, W; Chainakun, P; Ekprasert, J; Fongkaew, I; Kamngam, R | 1 |
12 review(s) available for limestone and calcium acetate
| Article | Year |
|---|---|
Current medical management of secondary hyperparathyroidism.
Topics: Acetates; Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Magnesium Compounds; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus, Dietary | 2000 |
Phosphate binder usage in kidney failure patients.
Topics: Acetates; Aluminum Compounds; Calcium Carbonate; Calcium Compounds; Clinical Trials as Topic; Epoxy Compounds; Humans; Iron Compounds; Ketoglutaric Acids; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Humans; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
[Clinical aspect of recent progress in phosphate metabolism. Management of hyperphosphagtemia].
Topics: Acetates; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Design; Gels; Humans; Hyperphosphatemia; Lanthanum; Macromolecular Substances; Phosphorus, Dietary; Polyamines; Polymers; Renal Dialysis; Sevelamer | 2009 |
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Chronic Disease; Humans; Kidney Diseases; Lanthanum; Polyamines; Sevelamer | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
Topics: Acetates; Aged; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chelation Therapy; Diet Therapy; Evidence-Based Medicine; Humans; Hyperphosphatemia; Nephrology; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic; United States | 2013 |
Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
Topics: Acetates; Adult; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperphosphatemia; Male; Renal Dialysis | 2015 |
6 trial(s) available for limestone and calcium acetate
| Article | Year |
|---|---|
Effect of phosphate binders on supplemental iron absorption in healthy subjects.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Biological Availability; Calcium Carbonate; Calcium Compounds; Cross-Over Studies; Drug Interactions; Epoxy Compounds; Female; Humans; Intestinal Absorption; Iron; Male; Phosphates; Polyamines; Polyethylenes; Sevelamer | 2002 |
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Topics: Acetates; Aortic Valve; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Heart Valve Diseases; Humans; Kidney Failure, Chronic; Mitral Valve; Multivariate Analysis; Renal Dialysis; Tomography, X-Ray Computed | 2004 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Coronary Vessels; Diabetes Mellitus; Female; Humans; Hypoparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Topics: Acetates; Adult; Age Factors; Aged; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cost-Benefit Analysis; Drug Costs; Follow-Up Studies; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Medicaid; Medicare; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome; United States | 2009 |
22 other study(ies) available for limestone and calcium acetate
| Article | Year |
|---|---|
Phosphate binders do not compromise the copper status of adult renal disease patients on hemodialysis.
Topics: Acetates; Adult; Aged; Aluminum Hydroxide; Antacids; Calcium Carbonate; Calcium Compounds; Ceruloplasmin; Copper; Erythrocytes; Female; Humans; Male; Middle Aged; Nutritional Physiological Phenomena; Phosphorus; Renal Dialysis; Renal Insufficiency; Superoxide Dismutase | 2000 |
Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
Topics: Acetates; Aluminum; Aluminum Hydroxide; Cadmium; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Case-Control Studies; Chelating Agents; Chi-Square Distribution; Copper; Cross-Sectional Studies; Erythropoietin; Female; Hematocrit; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Lead; Male; Mercury; Metals; Middle Aged; Phosphates; Renal Dialysis; Spectrophotometry, Atomic; Sucralfate; Trace Elements; Zinc | 2000 |
Calcium on trial: beyond a reasonable doubt?
Topics: Acetates; Calcium; Calcium Carbonate; Calcium Compounds; Humans; Hypercalcemia; Kidney Failure, Chronic; Renal Dialysis | 2003 |
The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
Topics: Acetates; Bone and Bones; Calcium Carbonate; Calcium Compounds; Dietetics; Epoxy Compounds; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphates; Phosphorus, Dietary; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2003 |
Renal disease medications and evidence-biased medicine.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Evidence-Based Medicine; Humans; Kidney Diseases | 2003 |
[MIBI and parathyroid gland function in secondary hyperparathyroidism].
Topics: Acetates; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Secretory Rate; Technetium Tc 99m Sestamibi; Uremia | 2004 |
Phosphate binders.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2006 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
[Fluorine removal efficiency of organic-calcium during coal combustion].
Topics: Absorption; Acetates; Air Pollutants; Calcium Carbonate; Calcium Compounds; Coal; Fluorine; Hot Temperature; Sulfur; Waste Management | 2006 |
Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement.
Topics: Acetates; Aged; Calcium Carbonate; Calcium Compounds; Female; Humans; Male; Phosphates; Thyrotropin; Thyroxine | 2007 |
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
Topics: Acetates; Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium Carbonate; Calcium Compounds; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Renal Dialysis | 2009 |
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Compounds; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Middle Aged; New York; Nutritional Status; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Serum Albumin; Sevelamer; Treatment Outcome | 2011 |
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiography; Renal Dialysis; Risk Factors; Serum Albumin; Sex Factors; Vascular Calcification | 2011 |
Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients.
Topics: Acetates; Adult; Aged; Calcium Carbonate; Calcium Compounds; Cohort Studies; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2011 |
Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
Topics: Acetates; Alginates; Calcium Carbonate; Calcium Compounds; Calorimetry, Differential Scanning; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Drug Design; Gastric Juice; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Intestinal Secretions; Intestines; Kinetics; Microscopy, Electron, Scanning; Models, Biological; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical | 2011 |
Absorption of levothyroxine when coadministered with various calcium formulations.
Topics: Absorption; Acetates; Adolescent; Adult; Calcium Carbonate; Calcium Citrate; Calcium Compounds; Calcium, Dietary; Drug Interactions; Drug Synergism; Female; Humans; Male; Thyroid Gland; Thyroxine | 2011 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
Drug release, preclinical and clinical pharmacokinetics relationships of alginate pellets prepared by melt technology.
Topics: Acetates; Alginates; Calcium Carbonate; Calcium Compounds; Chlorpheniramine; Drug Liberation; Excipients; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Solubility; Technology, Pharmaceutical | 2016 |
Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Combinations; Ferric Compounds; Hydrogen-Ion Concentration; Kinetics; Lanthanum; Magnesium; Phosphates; Sevelamer; Sucrose | 2019 |
Investigating mechanical properties and biocement application of CaCO
Topics: Acetates; Bacillaceae; Bone Cements; Calcium Carbonate; Calcium Chloride; Calcium Compounds; Crystallization; Neural Networks, Computer; Nitrates | 2020 |